InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Daniels Eric Joseph, Directeur du Développement. Officer active across 1 company, notably Kiora Pharmaceuticals INC. Aggregated, 10 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €7k. History available since 21 October 2022. The latest transaction was filed on 1 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Daniels Eric Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
929 shares@ US$1.9518.1% of flowCommon StockSEC:0001372514-26-000032:0
6,533 shares0Common StockSEC:0001372514-26-000014:0
238 shares@ US$2.024.6% of flowCommon StockSEC:0001372514-26-000007:0
7,772 shares0Common StockSEC:0001372514-25-000035:0
7,355 shares0Common StockSEC:0001372514-24-000094:0
1,431 shares@ US$5.29100.0% of flowCommon StockSEC:0001372514-24-000063:0
Canonical exit: 12 Sept 2024 (T+90)
62,500 shares0Common StockSEC:0001372514-23-000149:0
15,600 shares0Common StockSEC:0001372514-23-000034:0
10,000 shares0Common StockSEC:0001104659-22-111246:0
9,520 sharesCommon StockSEC:0001104659-21-142530:0
10 of 10 declarations
About Daniels Eric Joseph
Daniels Eric Joseph is Chief Development Officer. He has 10 filings in total, all associated with Kiora Pharmaceuticals INC, with buy transactions totaling EUR 7049 and no sell transactions in the sampled filings, over the period from 2021-11-22 to 2026-04-02. The modal transaction nature is Attribution.
